Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. — CFSMEATLAS
Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes, Michael, Twisk, Frank N M, Kubera, Marta et al. · Journal of affective disorders · 2012 · DOI
Quick Summary
This study examined whether people with ME/CFS have higher levels of inflammatory markers—substances in the blood that signal inflammation—compared to healthy people and those with regular fatigue. Researchers found that ME/CFS patients had significantly elevated levels of five different inflammatory markers, and these markers were linked to common ME/CFS symptoms like fatigue, brain fog, and flu-like feelings. The findings suggest that low-grade inflammation in the body may be contributing to ME/CFS symptoms.
Why It Matters
This research provides objective biological evidence that ME/CFS involves measurable inflammation and immune activation, potentially validating patient experiences and supporting the biological nature of the illness. These findings could help distinguish ME/CFS from other fatigue conditions and may guide development of anti-inflammatory treatments.
Observed Findings
All five inflammatory markers (IL-1, TNF-α, PMN-elastase, neopterin, lysozyme) were significantly elevated in ME/CFS patients compared to both healthy controls and chronic fatigue patients
IL-1 and TNF-α levels correlated with fatigue, sadness, autonomic symptoms, and flu-like malaise
PMN-elastase elevation correlated specifically with concentration difficulties, memory problems, and subjective infection feelings
Neopterin correlated with fatigue, autonomic symptoms, and flu-like malaise
A gradient of PMN-elastase was observed: controls < chronic fatigue patients < ME/CFS patients
Inferred Conclusions
ME/CFS is characterized by low-grade, persistent inflammation and activated cell-mediated immunity distinct from simple chronic fatigue
Inflammatory cytokines (IL-1, TNF-α) may be direct mediators of core ME/CFS symptoms including fatigue, autonomic dysfunction, and malaise
Different inflammatory markers correlate with different symptom clusters, suggesting multiple inflammatory pathways contribute to the heterogeneous symptom presentation
Remaining Questions
Do these inflammatory markers change over time within individual patients, and do they correlate with disease progression or remission?
What This Study Does Not Prove
This study shows correlation between inflammatory markers and symptoms, but does not prove that inflammation causes ME/CFS symptoms—the relationship could be bidirectional or indirect. The cross-sectional design cannot establish whether these inflammatory changes precede, follow, or are a consequence of ME/CFS development. Results are associational and do not establish that reducing these markers would improve symptoms.